Foresite Capital Management IV, LLC
Top Portfolio Positions
8 positions ·
$237,082,218 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| PHVS |
Pharvaris N.V.
Healthcare
|
4,778,581 | $134,994,913 | 56.94% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
503,295 | $33,172,173 | 13.99% | |
| EIKN |
Eikon Therapeutics, Inc.
Healthcare
|
1,943,682 | $20,564,155 | 8.67% | |
| LYEL |
Lyell Immunopharma, Inc.
Healthcare
|
800,399 | $16,056,003 | 6.77% | |
| RLAY |
Relay Therapeutics, Inc.
Healthcare
|
1,000,000 | $9,950,000 | 4.20% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
160,000 | $9,304,000 | 3.92% | |
| ALEC |
Alector, Inc.
Healthcare
|
3,887,200 | $8,357,480 | 3.53% | |
| MAZE |
Maze Therapeutics, Inc.
Healthcare
|
156,901 | $4,683,494 | 1.98% |
Portfolio Trend
25 quarters · across all stocks
Holdings in EIKN
1 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,564,155 | 1,943,682 | Shares | Sole | 2026-05-15 | |
| No 13F history on record for this holder in this stock. | ||||||